Cardiovascular management of septic shock.
Dellinger
R Phillip
RP
Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Section of Critical Care Medicine, Cooper Health System, Camden 08103, USA. Dellinger-Phil@cooperhealth.edu
D000465:Algorithms; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002319:Cardiovascular System / Q000187:drug effects / Q000503:physiopathology; D003422:Critical Care / Q000379:methods; D003663:Decision Trees; D005440:Fluid Therapy / Q000379:methods; D006801:Humans; D015994:Incidence; D008991:Monitoring, Physiologic / Q000379:methods; D010101:Oxygen Consumption / Q000187:drug effects; D011486:Protein C / Q000627:therapeutic use; D012151:Resuscitation / Q000379:methods; D012772:Shock, Septic / Q000175:diagnosis* / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D013256:Steroids; D016896:Treatment Outcome; D014662:Vasoconstrictor Agents / Q000627:therapeutic use; D014667:Vasopressins / Q000502:physiology
D000893:Anti-Inflammatory Agents; D001639:Bicarbonates; D002316:Cardiotonic Agents; D011486:Protein C; D013256:Steroids; D014662:Vasoconstrictor Agents; D014667:Vasopressins